| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
CEO | Director | President And CEO
2 companies
Doshi Dipal is a CEO at Entrada Therapeutics, Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 17 sells.
Estimated insider holdings value: $3.8M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 28, 2022 | TRDA Entrada Therapeutics, Inc. | President And CEO | Sell | 10,587 | $15.25 | $161,441.70 | -1.0% | -4.7% | +2.3% | |
| Sep 23, 2022 | TRDA Entrada Therapeutics, Inc. | President And CEO | Sell | 4,425 | $15.10 | $66,837.83 | -1.0% | +1.8% | -4.4% | |
| Sep 15, 2022 | TRDA Entrada Therapeutics, Inc. | President And CEO | Sell | 200 | $15.04 | $3,008.00 | - | +38.9% | +15.2% | |
| Sep 9, 2022 | TRDA Entrada Therapeutics, Inc. | President And CEO | Sell | 1,788 | $15.12 | $27,039.50 | -0.4% | +40.8% | -4.5% | |
| Aug 31, 2022 | TRDA Entrada Therapeutics, Inc. | President And CEO | Sell | 2,000 | $12.72 | $25,435.10 | -0.2% | +11.4% | +16.5% | |
| Jul 27, 2022 | TRDA Entrada Therapeutics, Inc. | President And CEO | Sell | 2,000 | $12.00 | $24,000.00 | -0.9% | +71.1% | +38.1% | |
| Jun 27, 2022 | TRDA Entrada Therapeutics, Inc. | President And CEO | Sell | 4,000 | $12.00 | $48,000.00 | -1.9% | +19.2% | -1.3% |